Tag Archives: Yaron Werber

Analysts Offer Insights on Healthcare Companies: Zafgen (NASDAQ: ZFGN) and Pharming Group (Other OTC: PHGUF)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zafgen (ZFGN – Research Report) and Pharming Group (PHGUF – Research Report). Zafgen (ZFGN) Cowen & Co. analyst Yaron Werber maintained a Hold rating on

Cowen & Co. Thinks BeiGene Ltd’s Stock is Going to Recover

In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on BeiGene Ltd (BGNE – Research Report), with a price target of $170. The company’s shares opened today at $118.28, close to its 52-week low

Cowen & Co. Maintains a Hold Rating on Zafgen (ZFGN)

In a report released today, Yaron Werber from Cowen & Co. maintained a Hold rating on Zafgen (ZFGN – Research Report). The company’s shares opened today at $2.29, close to its 52-week low of $1.88. According to TipRanks.com, Werber is

Cowen & Co. Maintains a Buy Rating on Epizyme (EPZM)

In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Buy rating on Epizyme (EPZM – Research Report), with a price target of $18. The company’s shares closed yesterday at $11.46. According to TipRanks.com, Werber is a

Cowen & Co. Sticks to Their Buy Rating for Alector Inc (ALEC)

Cowen & Co. analyst Yaron Werber maintained a Buy rating on Alector Inc (ALEC – Research Report) yesterday. The company’s shares closed yesterday at $19.82. According to TipRanks.com, Werber is a 5-star analyst with an average return of 13.4% and

Acceleron Pharma (XLRN) Receives a Buy from Cowen & Co.

Cowen & Co. analyst Yaron Werber maintained a Buy rating on Acceleron Pharma (XLRN – Research Report) on May 9 and set a price target of $78. The company’s shares closed on Friday at $41.48. According to TipRanks.com, Werber is